Smoking Status
7
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Quality of Life of Patients Who Have Undergone Bilateral Mastectomy
Effectiveness of NeoMayor in Improving Cardiovascular Health
Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention
Media Literacy to Prevent Adolescent Smoking
An Integrated Intervention to Reduce Secondhandsmoke in Children
Evaluation of Adolescent Smoking Cessation Programs
Analysis of 'Tobacco and Alcohol Tax Law' and Its Impact on Cigarette Consumption